Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yokukansankachimpihange is a traditional Japanese Kampo medicine developed and manufactured by Tsumura & Co. It is a modified version of the classic Yokukansan formula, created by adding *Citrus unshiu* peel (Chimpi) and *Pinellia ternata* tuber (Hange) to the original seven-herb preparation. This modification is intended to improve efficacy in patients with gastrointestinal weakness or chronic symptoms. The medicine is primarily used to treat neurosensory symptoms such as irritability, agitation, and insomnia. In clinical research, it is specifically being evaluated for its ability to manage behavioral and psychological symptoms of dementia (BPSD) in patients with dementia with Lewy bodies (DLB). Its pharmacological effects are attributed to its multi-component nature, which modulates the serotonergic and glutamatergic systems, including 5-HT2A receptor antagonism and enhancement of glutamate clearance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yokukansankachimpihange.